SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-014621
Filing Date
2020-05-29
Accepted
2020-05-29 19:17:59
Documents
2
Period of Report
2020-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6162
2 EX-24 DOCUMENT attachment1.htm EX-24 4903
  Complete submission text file 0000899243-20-014621.txt   12529
Mailing Address 84 WATERFORD DRIVE MARLBOROUGH MA 01752
Business Address
Iwicki Mark T (Reporting) CIK: 0001415537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 20930311

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences